Amplitude arrives at Thursday's Q1 report in a materially different shape than it did three months ago — the stock is up 12.6% on the week and 16.2% over the past month, yet short sellers have barely flinched, and the Street's analysts still carry targets well above the current price.
The most striking feature of the week is the divergence between the price rally and short positioning. Short interest has barely moved, edging up just 0.6% on the week to 6.8% of the free float — roughly 7.06 million shares. That level is actually lower than where it stood through most of April, when shorts peaked near 7.6 million shares in mid-month before unwinding sharply around April 23rd. The lending market reflects the same calm: borrow costs have climbed 14% on the week to 0.70% APR — a notable uptick in percentage terms, but still low in absolute terms and a fraction of where stressed names trade. Availability remains loose, and with the ORTEX short score at 43, well below the levels that typically flag a squeeze setup, the shorts are not the story here.
Options positioning has shifted noticeably over the past two weeks, and the direction tells an interesting story. The put/call ratio dropped sharply from readings above 0.82 in mid-to-late April down to 0.71 now — meaning options traders have rotated toward calls as the stock rallied. The ratio is slightly above its 20-day average of 0.64, at a z-score of just 0.38, so this is not a crowded bullish bet. It is, however, a clear reversal from the more defensive skew seen during April's volatility. The 52-week range on the PCR runs from 0.07 to 1.27, placing the current reading well within normal bounds.
The Street provides the clearest context for what the market is watching. Analysts covering AMPL are uniformly constructive on the direction of the business, even as they've trimmed targets. The most recent action came from Piper Sandler in April, cutting the target to $9 from $10 while holding Overweight — and the pattern from February's earnings was similar across UBS, DA Davidson, Keybanc, and BTIG, all maintaining Buy or Overweight ratings while pulling numbers down following last quarter's guidance. The consensus mean target is $11.40 against a $7.95 close, implying 43% upside — the screening data confirms analyst return potential running at that level. The bull case centres on AI-driven product momentum and a new pricing strategy improving customer economics. The bear focuses on profitability: Amplitude's non-GAAP operating margin guidance remains below the SaaS peer median, and limited free cash flow generation is the key overhang keeping valuations from re-rating more aggressively. The EV/EBITDA multiple has eased to 36.4x, down about 2.1 turns over the past month — a modest compression as the equity has re-rated upward.
One dynamic worth flagging in the ownership data is the co-founder and CTO, Curtis Liu, whose stake dropped by more than 7.3 million shares in the most recently reported period. That is a significant reduction for a founding shareholder and reflects a continued pattern of insider selling at levels ranging from $6.34 to $8.01 since February. CEO Spenser Skates also trimmed in December. These transactions appear to be pre-planned disposals rather than reaction to any specific catalyst, but the pace is notable context heading into a result where management's tone on full-year guidance will carry considerable weight.
The last earnings print provided an encouraging benchmark. February's Q4 release sent the stock 12.9% higher on the day and an additional 5% over the following week — the company beat on both the top line and key leading indicators. Close peer FRSH is up 10.9% on the week, and KVYO has surged 17%, suggesting the broader software cohort has caught a bid ahead of the reporting season. The RSI at 64 reflects momentum without yet reaching overbought territory. With Thursday's print now the singular focus, the setup is constructive rather than complacent — the question for bulls will be whether Q1 revenue execution and any Q2 or full-year guidance uplift can close the gap between the $7.95 stock and an analyst community still anchored around $10-$14.
See the live data behind this article on ORTEX.
Open AMPL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
